Clinical Trial Update: Pivotal Study of SAT-001 in Treatment of Pediatric Patient With Myopia [NA]

View source ↗

Summary

A pivotal study evaluating SAT-001 for treatment of pediatric myopia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• SAT-001

Snippet

Sponsor: S-Alpha Therapeutics, Inc. | Conditions: Myopia | NA | Status: RECRUITING